Some anti-diabetic therapies can have adverse effects on bone health and increase fracture
risk. In this study, we tested the skeletal effects of chronic administration of two Glucagon-like�…

A non-invasive evaluation of bone metabolism was performed in 44 morbidly obese patients
before and after a mean weight loss of 22.4 kg (range 7.9–43.4 kg) after 2 months and a�…

We evaluated the effects of recombinant insulin‐like growth factor‐I (IGF‐I) and growth
hormone (GH) on calciotropic hormones and bone turnover markers in 16 healthy elderly�…

Calcium plays a fundamental role as second messenger in intracellular signaling and bone
serves as the body's calcium reserve to tightly maintain blood calcium levels. Calcium in�…

Carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen (ICTP) in serum has
recently been proposed as a new biochemical marker of bone resorption. In the present�…

Introduction: Investigations in rodents as well as in vitro experiments have suggested an
anabolic influence of specific collagen peptides (SCP) on bone formation and bone mineral�…

This study examined whether markers of bone turnover differ between individuals with and
without diabetes. Bone markers showed heterogeneity between studies and were�…

Type I collagen, the major organic component of bone matrix, undergoes a series of post-
translational modifications that occur with aging, such as the non-enzymatic glycation. This�…

The objective of this study was to characterize changes in metabolic bone parameters
following bariatric surgery. Seventy‐three obese adult patients who underwent either gastric�…

Fragments of the α1 C-terminal telopeptide of type I collagen containing the sequence
AHDGGR1209-1214 (CTx) can be measured in urine as an index of bone resorption. We�…